ライフサイエンスコーパス: serum creatine kinase

1 ion and pathology and reduction in levels of serum creatine kinase.

2 ent, with significant reduction in levels of serum creatine kinase.

3 vere proximal weakness and markedly elevated serum creatine kinase.

4 thout causing pain or cramping or increasing serum creatine kinase.

5 are myalgias, myoglobinuria, and an elevated serum creatine kinase.

6 in muscle degeneration and concentrations of serum creatine kinase.

7 diotoxicity was evident by a 60% increase in serum creatine kinase activity and a 5-fold increase in

8 ongissimus lumborum and a 5-fold increase in serum creatine kinase activity compared with healthy mal

9 ency were a more than five times increase in serum creatine kinase activity or a >28% increase of liv

10 lly located myofiber nuclei and the level of serum creatine kinase activity were not decreased in DG/

11 damage, as evidenced by i) normal levels of serum creatine kinase activity, ii) a lack of Evans blue

12 ored contractile function and a reduction in serum creatine kinase activity.

13 Routine blood chemistry was normal, as were serum creatine kinase and aldolase levels and thyroid, h

14 tains sarcolemmal integrity as determined by serum creatine kinase and Evans blue uptake assays, and

15 emical analysis indicated that the levels of serum creatine kinase and lactate dehydrogenase in ADR-t

16 of adult onset muscular dystrophy with high serum creatine kinase and that mutation screening, parti

17 Total serum creatine kinase (CK) and cardiac TnT were measured

18 In the 14-day study, serum creatine kinase (CK) dropped by 50%, which was not

19 important myositis and rhabdomyolysis, mild serum creatine kinase (CK) elevations, myalgia with and

20 between the anti-Jo-1 antibody level and the serum creatine kinase (CK) level, as well as muscle and

21 Serum creatine kinase (CK) levels were lower (p = 0.025)

22 In addition, serum creatine kinase (CK) levels within the Oxford CMS

23 Manual muscle testing results, serum creatine kinase (CK) levels, and the daily cortico

24 timed Gower score, time to run 30 feet, and serum creatine kinase [CK] level) and with nonquantitati

25 's Blue dye uptake into muscle and increased serum creatine kinase compared to the 129T2/SvEmsJ backg

26 Total serum creatine kinase concentrations increased significa

27 in vivo, and resulted in large decreases in serum creatine kinase concentrations.

28 rhabdomyolysis is rare, muscle symptoms and serum creatine kinase elevations are sufficiently freque

29 These symptoms may occur with or without serum creatine kinase elevations.

30 Serum creatine kinase in all patients was at least 10 ti

31 Serum creatine kinase is elevated and muscle histology i

32 Serum creatine kinase level can be normal or only mildly

33 ity P = 0.45; I2 = 0%), and increases in the serum creatine kinase level were reduced (OR, 0.72 [CI,

34 g scale) of disease activity, the MMT score, serum creatine kinase level, and the Juvenile Arthritis

35 int contractures, severe scoliosis, elevated serum creatine kinase level, myopathic electrodiagnostic

36 leakiness throughout the body and normalized serum creatine kinase levels (a 50- to 100-fold drop).

37 Decreased serum creatine kinase levels (significant improvement fo

38 terized by adult onset muscle weakness, high serum creatine kinase levels and a prominent inflammator

39 in muscle degeneration, but had no effect on serum creatine kinase levels and muscle strength.

40 s less, Evans blue dye uptake is reduced and serum creatine kinase levels are lower.

41 ot associated with an increased incidence of serum creatine kinase levels that were more than 10 time

42 ber central nucleation, tissue fibrosis, and serum creatine kinase levels were dramatically reduced i

43 rs after MDMA treatment, blood was drawn and serum creatine kinase levels were measured as a marker o

44 Serum creatine kinase levels were normal in family membe

45 Serum creatine kinase levels were usually moderately hig

46 size distribution and significantly reduced serum creatine kinase levels, but had limited effect on

47 In addition, these mice show elevated serum creatine kinase levels, consistent with the myo-ne

48 muscle of Dmdmdx-5Cv mice results in reduced serum creatine kinase levels, improved sarcolemmal integ

49 This was associated with greatly reduced serum creatine kinase levels, near-normal histology, and

50 ular dystrophy by several standard measures; Serum creatine kinase levels, percentage of centrally lo

51 enhanced interstitial fibrosis and elevated serum creatine kinase levels.

52 , less Evans blue dye infiltration and lower serum creatine kinase levels.

53 rent abdominal pain, and moderately elevated serum creatine kinase levels.

54 y as determined by muscle histopathology and serum creatine kinase levels.

55 thologic findings of myopathy despite normal serum creatine kinase levels.

56 etic resonance imaging, and through elevated serum creatine kinase levels.

57 We monitored serum creatine kinase levels; changes in peak cycle work

58 value of serum levels of cardiac troponin T, serum creatine kinase MB (CK-MB) levels, and electrocard

59 Elevation of serum creatine kinase MB fraction (CK-MB) after percutan

60 Serum creatine kinase-MB (CK-MB) and cardiac troponin T

61 dial infarction </=1 flow, there was reduced serum creatine kinase (P=0.030) and a 19% reduction in c

62 ntegrin, stabilized the sarcolemma, restored serum creatine kinase to wild-type levels, and protected

63 ximal lower limb weakness with highly raised serum creatine kinase values (average 4500 IU/l) and fre

64 ion of muscular dystrophy or persistent high serum creatine kinase values (hyperCKemia).

65 Serum creatine kinase values were usually normal or slig

66 Serum creatine kinase was usually mildly elevated (363 +